As previously reported, Wells Fargo analyst Brandon Couillard upgraded CareDx (CDNA) to Equal Weight from Underweight with a price target of $24, down from $28. With shares down about 30% since late August, the firm sees a more balanced risk/reward setup with relative valuation now at a wide discount to peers, despite similar gross margin and low/mid-teens growth outlooks through 2026.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CDNA: